From Discovery To Development To Delivery

AZBio is committed to building a top-tier life science industry in Arizona.

Arizona’s bioscience industry has grown in recent years and by 2014 state bioscience firms employed just over 24,000 in nearly 1,300 business establishments. Four of the state’s five bioscience subsectors have contributed to its 2 percent overall employment gain since 2012, led by double-digit job growth in medical devices (up 11 percent). State academic institutions accounted for nearly $400 million in bioscience-related R&D expenditures in 2014 and NIH funding to these and other non-academic institutions totaled $150.6 million in 2015. Arizona inventors have had 1,751 patents issued in bioscience-related classes since 2012, primarily in medical and surgical devices but also in drugs and pharmaceuticals, microbiology and genetics, and in biochemistry. The state has seen a strong increase in venture capital invested in bioscience-related companies in recent years.  (Get The Facts)

AZBio Members Are Making LIFE Bettter

AZBio Members discover, develop, and deliver life-saving and life-changing innovations.

Premiere Supporters

Leadership Supporters

Sustaining Members

Get Connected With Arizona's Bioindustry

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry.  AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.

Success Stories – Good News from Arizona’s BioIndustry

Paradigm Announces Major Price Reduction in Flagship Paradigm Cancer Diagnostic (PCDx)

On July 24, 2017, Paradigm Diagnostics announced a major price reduction of PCDx.  “The efficiency of our proprietary process and transition to an optimized platform enables us to share the savings with our patients, customers, research partners, and distributors without impacting our industry leading accuracy, speed, and comprehensiveness,” said David Mallery, CEO.

AZBio In the Loop for the week of July 24, 2017

    AZBio just posted who will be honored at the  2017 AZBio Awards.  Check it out! Beginning in August, watch for a new story each week featuring our  2017 AZBio Award Honorees.     AZBio Member News Partnering with U.S. Army to improve Ebola detection To catch a serial killer, homicide detectives must quickly and [...]

Partnering with U.S. Army to improve Ebola detection

To catch a serial killer, homicide detectives must quickly and accurately find clues. Trace evidence left at a crime scene will eventually reveal the killer’s presence and identity, but the detectives first have to know what to look for.

AZBio Builds Relationships With Partners Across The Country

Partner Opportunities for AZBio Members

  • AZBio Members Save at BMES 2017. Click here to learn more.